Micro-Tech (Nanjing)Ltd (SHSE:688029) Could Be Struggling To Allocate Capital
Micro-Tech (Nanjing)Ltd (SHSE:688029) Could Be Struggling To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. Having said that, from a first glance at Micro-Tech (Nanjing)Ltd (SHSE:688029) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look.
在长期内,我们应该寻找哪些早期趋势,以确定一个股票的价值可能会成倍增长?理想情况下,一家企业将展现两种趋势;首先是不断增长的资本利用率(ROCE),其次是不断增加的资本利用金额。最终,这表明这是一家以增加的投资回报率再投资利润的企业。话虽如此,初步看南微医学(南京)股份有限公司(SHSE:688029),我们并不觉得收益趋势如何,但让我们细看一下。
Understanding Return On Capital Employed (ROCE)
上面您可以看到蒙托克可再生能源现行ROCE与之前资本回报的比较,但过去只能知道这么多。如果您感兴趣,可以查看我们免费的蒙托克可再生能源分析师报告,了解分析师的预测。
For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for Micro-Tech (Nanjing)Ltd, this is the formula:
对于那些不清楚什么是ROCE的人,它衡量了一家公司能从其业务中使用的资本中产生多少税前利润。要为南微医学(南京)股份有限公司计算这一指标,这是公式:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
资产雇用回报率(ROCE)是指企业利润,即企业税前利润除以企业投入的总资本(负债加股权)。如果ROCE高于企业财务成本的承受能力,那么企业就会创造出更多的价值。
0.14 = CN¥550m ÷ (CN¥4.4b - CN¥578m) (Based on the trailing twelve months to June 2024).
0.14 = 55000万人民币 ÷(44000000000 - 578000000)(截至2024年6月的过去十二个月)。
So, Micro-Tech (Nanjing)Ltd has an ROCE of 14%. On its own, that's a standard return, however it's much better than the 5.9% generated by the Medical Equipment industry.
因此,南微医学(南京)股份有限公司的ROCE为14%。单独看,这是一个标准回报,但比医疗设备行业的5.9%要好得多。
In the above chart we have measured Micro-Tech (Nanjing)Ltd's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for Micro-Tech (Nanjing)Ltd .
在上面的图表中,我们已经测量了南微医学(南京)有限公司之前的资本回报率与其之前的表现,但未来无疑更为重要。如果您想了解分析师对未来的预测,请查看我们为南微医学(南京)有限公司制作的免费分析师报告。
What Does the ROCE Trend For Micro-Tech (Nanjing)Ltd Tell Us?
南微医学(南京)有限公司的资本回报率趋势给我们带来了什么信息?
When we looked at the ROCE trend at Micro-Tech (Nanjing)Ltd, we didn't gain much confidence. Over the last five years, returns on capital have decreased to 14% from 32% five years ago. Although, given both revenue and the amount of assets employed in the business have increased, it could suggest the company is investing in growth, and the extra capital has led to a short-term reduction in ROCE. If these investments prove successful, this can bode very well for long term stock performance.
当我们查看南微医学(南京)有限公司的资本回报率趋势时,我们并没有获得太多信心。在过去的五年中,资本回报率从32%下降到了14%。尽管营业收入和业务中使用的资产规模都增加了,这可能表明公司正在投资于增长,而额外的资本导致了短期资本回报率的降低。如果这些投资证明成功,这对于长期股票表现可能非常有利。
On a related note, Micro-Tech (Nanjing)Ltd has decreased its current liabilities to 13% of total assets. That could partly explain why the ROCE has dropped. What's more, this can reduce some aspects of risk to the business because now the company's suppliers or short-term creditors are funding less of its operations. Some would claim this reduces the business' efficiency at generating ROCE since it is now funding more of the operations with its own money.
相关的是,南微医学(南京)有限公司将其流动负债降低至总资产的13%。这可能部分解释了为什么资本回报率下降。此外,这可以减少一些业务方面的风险,因为现在公司的供应商或短期债权人资助其运营的比例减少了。有人会称这降低了公司通过自有资金资助更多运营的效率,因为它现在更多地用自有资金资助运营。
In Conclusion...
最后,同等资本下回报率较低的趋势通常不是我们关注创业板股票的最佳信号。由于这些发展进行良好,因此投资者不太可能表现友好。自五年前以来,该股下跌了32%。除非这些指标朝着更积极的轨迹转变,否则我们将继续寻找其他股票。
In summary, despite lower returns in the short term, we're encouraged to see that Micro-Tech (Nanjing)Ltd is reinvesting for growth and has higher sales as a result. These growth trends haven't led to growth returns though, since the stock has fallen 40% over the last five years. As a result, we'd recommend researching this stock further to uncover what other fundamentals of the business can show us.
总而言之,尽管短期内回报率较低,但我们很高兴看到南微医学(南京)有限公司正在为增长进行再投资,营业收入也因此增加。但是,这些增长趋势并没有带来收益增长,因为股价在过去五年中下跌了40%。因此,我们建议进一步研究这支股票,以揭示业务的其他基本因素。
One more thing to note, we've identified 1 warning sign with Micro-Tech (Nanjing)Ltd and understanding this should be part of your investment process.
还有一件事需要注意,我们已经发现南微医学(南京)有1个风险警示,了解这一点应该成为您投资过程的一部分。
While Micro-Tech (Nanjing)Ltd isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
虽然南微医学(南京)的回报率不是最高的,但请查看这份免费的公司列表,这些公司在股权回报率和健康资产负债表方面获得了高回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。